Here are six takeaways:
1. The aging population and increasing number of neurological disorder cases will spur market growth in the forecast period.
2. A dearth of skilled professionals in developing countries as well as unfavorable reimbursements will hinder the market.
3. Currently, North America dominates the market, because of the high neurosurgical case volume in this region.
4. Europe follows North America in market share, because of its technological advancements in the healthcare industry.
5. The Asia-Pacific region is anticipated to grow, due to market opportunity in India and China.
6. Key market players include:
• Karl Storz GmbH & Co. in Tuttlingen, Germany
• Olympus Corp. in Center Valley, Pa.
• Conmed Corp. in Utica, N.Y.
• Richard Wolf in Vernon Hills, Ill.
• Boston Scientific in Rolling Meadows, Ill.
• Integra LifeSciences Holdings Corp. in Plainsboro, N.J.
• Aesculap in Center Valley, Pa.
• Smith & Nephew in London, U.K.
• Medtronic in Dublin, Ireland
• NICO Corp. in Carmel, Ind.
More articles on devices:
Watchdog told Medicare and Medicaid EpiPen was improperly classified in 2009: 4 things to know
Globus Medical reports Q3 revenue of $135.7M — 5 highlights
University of Iowa Hospitals and Clinics joins InVivo Therapeutics’ INSPIRE Study: 5 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
